Which has stronger valuation & earnings, MCK or HQY?

McKesson has higher revenue and earnings than HealthEquity. McKesson is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.25 $4.76B $37.37 23.56 HealthEquity $1.36B 5.85 $215.20M $2.77 34.75

Is MCK or HQY more profitable?

HealthEquity has a net margin of 17.36% compared to McKesson's net margin of 1.12%. HealthEquity's return on equity of 15.33% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.12% -253.21% 5.90% HealthEquity 17.36% 15.33% 9.51%

Does the media refer more to MCK or HQY?

In the previous week, McKesson had 25 more articles in the media than HealthEquity. MarketBeat recorded 32 mentions for McKesson and 7 mentions for HealthEquity. McKesson's average media sentiment score of 1.08 beat HealthEquity's score of 1.04 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 26 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive HealthEquity 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, MCK or HSIC?

McKesson has higher revenue and earnings than Henry Schein. McKesson is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.25 $4.76B $37.37 23.56 Henry Schein $13.18B 0.75 $398M $3.43 25.76

Is MCK or HSIC more profitable?

Henry Schein has a net margin of 2.96% compared to McKesson's net margin of 1.12%. Henry Schein's return on equity of 15.97% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.12% -253.21% 5.90% Henry Schein 2.96% 15.97% 5.56%

Does the media favor MCK or HSIC?

In the previous week, McKesson had 26 more articles in the media than Henry Schein. MarketBeat recorded 32 mentions for McKesson and 6 mentions for Henry Schein. McKesson's average media sentiment score of 1.08 beat Henry Schein's score of 0.91 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 26 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Henry Schein 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MMSI or MCK?

In the previous week, McKesson had 28 more articles in the media than Merit Medical Systems. MarketBeat recorded 32 mentions for McKesson and 4 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.56 beat McKesson's score of 1.08 indicating that Merit Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive McKesson 26 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Which has preferable valuation & earnings, MCK or NEOG?

McKesson has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.25 $4.76B $37.37 23.56 Neogen $870.40M 2.95 -$7.90M -$0.03 N/A

Is MCK or NEOG more profitable?

McKesson has a net margin of 1.12% compared to Neogen's net margin of -0.91%. Neogen's return on equity of 2.78% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.12% -253.21% 5.90% Neogen -0.91% 2.78% 1.74%

Does the media favor MCK or NEOG?

In the previous week, McKesson had 22 more articles in the media than Neogen. MarketBeat recorded 32 mentions for McKesson and 10 mentions for Neogen. McKesson's average media sentiment score of 1.08 beat Neogen's score of 0.80 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 26 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Neogen 2 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to AMN or MCK?

In the previous week, McKesson had 29 more articles in the media than AMN Healthcare Services. MarketBeat recorded 32 mentions for McKesson and 3 mentions for AMN Healthcare Services. McKesson's average media sentiment score of 1.08 beat AMN Healthcare Services' score of 0.92 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive McKesson 26 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

McKesson (MCK) Competitors

$880.52 -0.35 (-0.04%)

Closing price 09/11/2026 03:58 PM Eastern

Extended Trading

$881.51 +1.00 (+0.11%)

As of 09/11/2026 07:57 PM Eastern

Compare

MCK vs. HQY, HSIC, MMSI, NEOG, and AMN

Should you buy McKesson stock or one of its competitors? McKesson's main competitors and comparable companies include HealthEquity (HQY), Henry Schein (HSIC), Merit Medical Systems (MMSI), Neogen (NEOG), and AMN Healthcare Services (AMN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does McKesson compare to HealthEquity?

McKesson (NYSE:MCK) and HealthEquity (NASDAQ:HQY) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, valuation and risk.

McKesson has a beta of 0.3, indicating that its stock price is 70% less volatile than the broader market. Comparatively, HealthEquity has a beta of 0.22, indicating that its stock price is 78% less volatile than the broader market.

McKesson has higher revenue and earnings than HealthEquity. McKesson is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.25	$4.76B	$37.37	23.56
HealthEquity	$1.36B	5.85	$215.20M	$2.77	34.75

85.1% of McKesson shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 0.1% of McKesson shares are held by insiders. Comparatively, 1.6% of HealthEquity shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, McKesson had 25 more articles in the media than HealthEquity. MarketBeat recorded 32 mentions for McKesson and 7 mentions for HealthEquity. McKesson's average media sentiment score of 1.08 beat HealthEquity's score of 1.04 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	26 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
HealthEquity	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity has a net margin of 17.36% compared to McKesson's net margin of 1.12%. HealthEquity's return on equity of 15.33% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.12%	-253.21%	5.90%
HealthEquity	17.36%	15.33%	9.51%

McKesson currently has a consensus target price of $973.44, suggesting a potential upside of 10.55%. HealthEquity has a consensus target price of $111.87, suggesting a potential upside of 16.21%. Given HealthEquity's stronger consensus rating and higher probable upside, analysts clearly believe HealthEquity is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.85

Summary

HealthEquity beats McKesson on 10 of the 17 factors compared between the two stocks.

How does McKesson compare to Henry Schein?

McKesson (NYSE:MCK) and Henry Schein (NASDAQ:HSIC) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.

Henry Schein has a net margin of 2.96% compared to McKesson's net margin of 1.12%. Henry Schein's return on equity of 15.97% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.12%	-253.21%	5.90%
Henry Schein	2.96%	15.97%	5.56%

McKesson has a beta of 0.3, suggesting that its share price is 70% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market.

85.1% of McKesson shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 0.1% of McKesson shares are held by company insiders. Comparatively, 0.9% of Henry Schein shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

McKesson currently has a consensus target price of $973.44, suggesting a potential upside of 10.55%. Henry Schein has a consensus target price of $92.93, suggesting a potential upside of 5.18%. Given McKesson's stronger consensus rating and higher probable upside, equities research analysts plainly believe McKesson is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78
Henry Schein	1 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.53

McKesson has higher revenue and earnings than Henry Schein. McKesson is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.25	$4.76B	$37.37	23.56
Henry Schein	$13.18B	0.75	$398M	$3.43	25.76

In the previous week, McKesson had 26 more articles in the media than Henry Schein. MarketBeat recorded 32 mentions for McKesson and 6 mentions for Henry Schein. McKesson's average media sentiment score of 1.08 beat Henry Schein's score of 0.91 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	26 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Henry Schein	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

McKesson beats Henry Schein on 9 of the 16 factors compared between the two stocks.

How does McKesson compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and McKesson (NYSE:MCK) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation and risk.

McKesson has higher revenue and earnings than Merit Medical Systems. McKesson is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.52B	3.40	$128.49M	$2.42	35.69
McKesson	$403.43B	0.25	$4.76B	$37.37	23.56

Merit Medical Systems has a beta of 0.49, suggesting that its stock price is 51% less volatile than the broader market. Comparatively, McKesson has a beta of 0.3, suggesting that its stock price is 70% less volatile than the broader market.

Merit Medical Systems currently has a consensus price target of $100.00, suggesting a potential upside of 15.79%. McKesson has a consensus price target of $973.44, suggesting a potential upside of 10.55%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, equities research analysts clearly believe Merit Medical Systems is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78

In the previous week, McKesson had 28 more articles in the media than Merit Medical Systems. MarketBeat recorded 32 mentions for McKesson and 4 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.56 beat McKesson's score of 1.08 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
McKesson	26 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Merit Medical Systems has a net margin of 9.22% compared to McKesson's net margin of 1.12%. Merit Medical Systems' return on equity of 13.75% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.22%	13.75%	8.10%
McKesson	1.12%	-253.21%	5.90%

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by insiders. Comparatively, 0.1% of McKesson shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Merit Medical Systems beats McKesson on 12 of the 17 factors compared between the two stocks.

How does McKesson compare to Neogen?

McKesson (NYSE:MCK) and Neogen (NASDAQ:NEOG) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability.

McKesson has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.25	$4.76B	$37.37	23.56
Neogen	$870.40M	2.95	-$7.90M	-$0.03	N/A

McKesson presently has a consensus price target of $973.44, indicating a potential upside of 10.55%. Neogen has a consensus price target of $12.00, indicating a potential upside of 1.87%. Given McKesson's stronger consensus rating and higher possible upside, research analysts clearly believe McKesson is more favorable than Neogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78
Neogen	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

McKesson has a net margin of 1.12% compared to Neogen's net margin of -0.91%. Neogen's return on equity of 2.78% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.12%	-253.21%	5.90%
Neogen	-0.91%	2.78%	1.74%

McKesson has a beta of 0.3, meaning that its share price is 70% less volatile than the broader market. Comparatively, Neogen has a beta of 1.76, meaning that its share price is 76% more volatile than the broader market.

85.1% of McKesson shares are owned by institutional investors. Comparatively, 96.7% of Neogen shares are owned by institutional investors. 0.1% of McKesson shares are owned by insiders. Comparatively, 0.5% of Neogen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, McKesson had 22 more articles in the media than Neogen. MarketBeat recorded 32 mentions for McKesson and 10 mentions for Neogen. McKesson's average media sentiment score of 1.08 beat Neogen's score of 0.80 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	26 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Neogen	2 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

McKesson beats Neogen on 11 of the 16 factors compared between the two stocks.

How does McKesson compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and McKesson (NYSE:MCK) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

AMN Healthcare Services pays an annual dividend of $1.20 per share and has a dividend yield of 3.6%. McKesson pays an annual dividend of $3.76 per share and has a dividend yield of 0.4%. AMN Healthcare Services pays out 44.8% of its earnings in the form of a dividend. McKesson pays out 10.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. McKesson has increased its dividend for 17 consecutive years.

AMN Healthcare Services has a net margin of 3.06% compared to McKesson's net margin of 1.12%. AMN Healthcare Services' return on equity of 19.92% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	3.06%	19.92%	5.93%
McKesson	1.12%	-253.21%	5.90%

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by company insiders. Comparatively, 0.1% of McKesson shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

McKesson has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$3.43B	0.38	-$95.70M	$2.68	12.44
McKesson	$403.43B	0.25	$4.76B	$37.37	23.56

In the previous week, McKesson had 29 more articles in the media than AMN Healthcare Services. MarketBeat recorded 32 mentions for McKesson and 3 mentions for AMN Healthcare Services. McKesson's average media sentiment score of 1.08 beat AMN Healthcare Services' score of 0.92 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
McKesson	26 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

AMN Healthcare Services currently has a consensus target price of $36.00, indicating a potential upside of 8.02%. McKesson has a consensus target price of $973.44, indicating a potential upside of 10.55%. Given McKesson's stronger consensus rating and higher probable upside, analysts clearly believe McKesson is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78

AMN Healthcare Services has a beta of 0.38, meaning that its share price is 62% less volatile than the broader market. Comparatively, McKesson has a beta of 0.3, meaning that its share price is 70% less volatile than the broader market.

Summary

McKesson beats AMN Healthcare Services on 11 of the 19 factors compared between the two stocks.

Get McKesson News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MCK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MCK vs. The Competition

Export

Metric	McKesson	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$102.70B	$9.88B	$7.16B	$23.20B
Dividend Yield	0.43%	2.61%	2.56%	3.56%
P/E Ratio	23.56	33.27	274.10	28.71
Price / Sales	0.25	5.55	656.00	94.45
Price / Cash	19.33	125.76	77.04	33.82
Price / Book	-60.68	5.29	10.33	4.74
Net Income	$4.76B	$313.25M	$3.50B	$1.07B
7 Day Performance	-2.96%	-1.26%	-3.35%	-2.00%
1 Month Performance	0.38%	-0.98%	-0.43%	-2.69%
1 Year Performance	23.79%	15.13%	19.21%	10.45%

McKesson Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MCK McKesson	4.6171 of 5 stars	$880.52 0.0%	$973.44 +10.6%	+22.5%	$102.70B	$403.43B	23.56	43,000	Positive News
HQY HealthEquity	4.2676 of 5 stars	$96.07 flat	$111.87 +16.4%	+4.2%	$7.95B	$1.31B	34.68	2,814	Positive News
HSIC Henry Schein	2.1183 of 5 stars	$89.81 flat	$92.93 +3.5%	+27.0%	$10.01B	$13.18B	26.18	25,000
MMSI Merit Medical Systems	3.3121 of 5 stars	$89.60 flat	$100.00 +11.6%	-4.3%	$5.35B	$1.52B	37.02	7,500	Positive News Gap Down
NEOG Neogen	1.8388 of 5 stars	$11.83 flat	$12.00 +1.4%	+105.2%	$2.58B	$870.40M	N/A	2,110	News Coverage Analyst Upgrade Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MCK) was last updated on 9/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

McKesson (MCK) Competitors

MCK vs. HQY, HSIC, MMSI, NEOG, and AMN

How does McKesson compare to HealthEquity?

Summary

How does McKesson compare to Henry Schein?

Summary

How does McKesson compare to Merit Medical Systems?

Summary

How does McKesson compare to Neogen?

Summary

How does McKesson compare to AMN Healthcare Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCK vs. The Competition

McKesson Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

McKesson (MCK) Competitors

MCK vs. HQY, HSIC, MMSI, NEOG, and AMN

How does McKesson compare to HealthEquity?

Which has more volatility and risk, MCK or HQY?

Which has stronger valuation & earnings, MCK or HQY?

Do institutionals and insiders have more ownership in MCK or HQY?

Does the media refer more to MCK or HQY?

Is MCK or HQY more profitable?

Do analysts rate MCK or HQY?

Summary

How does McKesson compare to Henry Schein?

Is MCK or HSIC more profitable?

Which has more volatility and risk, MCK or HSIC?

Do insiders & institutionals hold more shares of MCK or HSIC?

Do analysts prefer MCK or HSIC?

Which has better earnings and valuation, MCK or HSIC?

Does the media favor MCK or HSIC?

Summary

How does McKesson compare to Merit Medical Systems?

Which has better valuation & earnings, MMSI or MCK?

Which has more risk and volatility, MMSI or MCK?

Do analysts rate MMSI or MCK?

Does the media favor MMSI or MCK?

Is MMSI or MCK more profitable?

Do insiders and institutionals hold more shares of MMSI or MCK?

Summary

How does McKesson compare to Neogen?

Which has preferable valuation & earnings, MCK or NEOG?

Do analysts recommend MCK or NEOG?

Is MCK or NEOG more profitable?

Which has more volatility & risk, MCK or NEOG?

Do insiders & institutionals believe in MCK or NEOG?

Does the media favor MCK or NEOG?

Summary

How does McKesson compare to AMN Healthcare Services?

Is AMN or MCK a better dividend stock?

Is AMN or MCK more profitable?

Do institutionals and insiders believe in AMN or MCK?

Which has higher earnings & valuation, AMN or MCK?

Does the media refer more to AMN or MCK?

Do analysts rate AMN or MCK?

Which has more volatility & risk, AMN or MCK?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCK vs. The Competition

McKesson Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools